Treat patients with noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH), previously called nonalcoholic steatohepatitis (NASH), with moderate to advanced liver fibrosis (stages F2 to F3)
Designed based on an in-depth understanding of incretin biology, tirzepatide can simultaneously activate GLP-1 and GIP receptors, thereby exerting synergistic effects that translate into superior outcomes in glycemic control, body weight management, and pancreatic -cell function preservation (19, 20)
Ingredients Vitamin C Ester, Astragalus, Licorice Root, Carthamus Tinctorius (safflower) oil, Vitis Vinifera (Grape) Seed Oil, Cannabis Sativa (Hemp) Seed Oil, Glycyrrhiza Glabra Root Extract, Lentinus Edodes (Shitake) Extract
Pain 19, 953965
Tan B, Watson RR, Preedy VR